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These peaks are absent in unmethylated CDYL1 preparations. 
Supplementary Discussion
Summary of literature data on methylation and demethylation of nonhistone proteins at lysine residues. SET7/9 methylates p53 and TAF10 7, 8 . Symd2 and Set8 methylate p53 9,10 The S. cerevisia COMPASS complex methylates non-histone targets during chromosome segregation 11 . The Ezh2 complex methylates even cytosolic targets 12 . LSD1 demethylates p53 13 . In addition, cytochrome C and Rubisco are methylated at lysine residues as well 14 .
Examples of reading domains with preference for mono-or dimethyllysine residues.
Reading domains with preferential interaction with mono-or dimethylated lysine residues, which are candidates for an interaction with G9a methylated nonhistone proteins, include L3MBTL1 and ankyrin repeats. L3MBTL1 has been
shown to preferentially interact with mono-or dimethyllysine 15, 16 . The ankyrin repeats of G9a and Ga9-like protein (GLP) are H3K9me1 and H3K9me2 binding modules 17 . Hence the ankyrin repeats of G9a and GLP bind the epigenetic mark that is generated by G9a and GLP catalytic SET domains in vivo. It is tempting to speculate that the dual roles of methylating and methyl-binding contribute to the co-regulator function of G9a-containing complexes.
Supplementary Methods

Cloning and protein purification
A fragment encoding the C-terminal 280 residues of human G9a (the catalytic SET domain) was made as described 18 
Synthesis of peptide SPOT arrays
Peptide arrays were synthesized using the SPOT synthesis method 20,21 . Each spot had diameters of 2 mm and contained approximately 9 nmol of peptide (Autospot Reference Handbook, Intavis AG). Successful synthesis of each peptide was confirmed by bromphenol blue staining of the membranes.
Methylation of peptide arrays
The Fig. 1D , the discrimination factor of 6 for a glycine at position 7 indicates that the peptide with glycine at that position is methylated 6 times faster than the average of all peptides carrying any of the other amino acids at this site. Since the detection limit of the experiments was at about 3% of the full activity, the lower limit of the discrimination factors for R8 and K9, which both could not be replaced by any other residue, was 30.
Identification of potential non-histone targets
A Scansite search 24 
Reading domain binding to peptides arrays containing modified residues
After synthesis of the array, the cellulose membrane was blocked by immersing in TTBS buffer (10 mM Tris/HCl pH 8.3, 0.05% Tween-20 and 150 mM NaCl)
containing 5% non-fat dried milk at 4 °C overnight. After washing in TTBS buffer, the membrane was incubated with purified GST-tagged HP1ß or CDYL1 (10 nM)
at room temperature for 1 h in buffer containing 100 mM KCl, 20 mM HEPES pH 7.5, 1 mM EDTA, 0.1 mM DTT and 10% glycerol. After washing in TTBS buffer, the membrane was incubated with goat anti-GST antibody (GE Healthcare #27-4577-01, 1:10000 dilution) in TTBS buffer for 1 h at room temperature. After additional washing with TTBS, the membrane was incubated with horseradish peroxidase conjugated anti-Goat antibody (Invitrogen #81-1620 1:12000) in TTBS for 1 h at room temperature. Finally, the membrane was submerged in ECL developing solution (Amersham Pharmacia Biotech, Little Chalfont, Bucks., U.K.) and autoradiographed.
Detection of CDYL1 and WIZ methylation in vivo
Full length mouse G9a and flag-tagged full-length mouse Wiz or eGFP-NLShuman CDYL1 (residues 64-283) expression vectors (pCAGGS-G9aS and mG9aS, pCAGGS-lox-flag-WizmWiz or pEGFP-CDYL1) were transfected into HEK293T cells using a TransIT-LT1 lipofection reagent (Mirus). After 40 h transfection, total nuclear lysates were prepared using high salt extraction buffer containing 420 mM NaCl, 0.1% NP-40, 20 mM HEPES pH 7.5, and 1.5 mM MgCl 2 . Flag-tagged Wiz or eGFP-CDYL1 was immunoprecipitated by anti-Flag antibody (M2, Sigma) or anti-GFP antibody (Roche), respectively, and subjected to Western blot analysis. To detect lysine methylation and G9a, anti-pan methyllysine antibodies (MEK3D7 and MEK5B11,
